Bottom Line: This research letter reports on the association of BRCA2 gene mutations and potential risk for pediatric or adolescent lymphoma. The study used whole-genome sequencing data for 1,380 survivors of pediatric or adolescent lymphoma (815 survivors of Hodgkin lymphoma and 565 survivors of non-Hodgkin lymphoma), of which 13 survivors had BRCA2 mutations (five survivors of Hodgkin lymphoma and eight survivors of non-Hodgkin lymphoma). Compared with individuals without cancer, there was a statistically significant association between BRCA2 mutations and risk of non-Hodgkin lymphoma but not Hodgkin lymphoma. The findings support including childhood non-Hodgkin lymphoma in the spectrum of cancers associated with BRCA2 mutations.
Authors: Zhaoming Wang, Ph.D., St. Jude Children's Research Hospital, Memphis, Tennessee, and coauthors
Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Embed this link to provide your readers free access to the full-text article: This link will be live at the embargo time: https://jamanetwork.com/journals/jamaoncology/fullarticle/2738771?guestAccessKey=075f0ca3-2467-4f3b-86f3-53ad8cb84ea5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072519